Sichenzia Ross Ference represented Relmada Therapeutics in the offering.Relmada Therapeutics executed its offering which included the full exercise of the overallotment, consisted of 10,147,059 shares of common stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
